Topic: Genetic Engineering

The hosts revisit their early coverage of COVID-19, specifically citing French Nobel laureate Luc Montagnier. They recall Montagnier's early claims that the virus appeared engineered and would naturally decay over time. They use this as an example of why independent media can "turn on a dime" compared to institutional outlets.

Moderna CEO Stéphane Bancel discussed the future of mRNA technology, describing it as an "information molecule" that can turn the human body into its own drug factory. Bancel highlighted clinical programs aimed at treating rare genetic diseases in children's livers and injecting mRNA into the heart to regrow blood vessels after heart attacks. He characterized the technology as "science fiction medicine" that moves beyond traditional preventative vaccines into active genetic modification.

The global elite are increasingly viewing death as a technical problem with a potential technical solution. Harari posits that in the future, the wealthy may buy an "exemption from death" through advanced medicine and genetic engineering, while the poor continue to die. This transhumanist agenda is championed by Silicon Valley figures like Ray Kurzweil, who believe biological limitations can be overcome through technology.

Investors have poured $5 million into the world's first large-scale genetic breeding facility for mealworms. These genetically engineered insects are being positioned as a sustainable source of fertilizer and protein for human consumption, a trend the hosts have tracked for over a decade.

A 2017 speech by Bill Gates at the Munich Security Conference is being revisited for its warnings about synthetic versions of smallpox or deadly flu strains created via genetic engineering. Gates predicted that a respiratory pathogen could kill 30 million people within a year, emphasizing the link between international security and health security. While some view these remarks as prophetic, others suggest they reflect long-standing concerns within the global health community regarding bioterrorism.

Researchers at Edinburgh University proposed releasing genetically mutated rats into the UK population to combat rising rodent numbers in London. Using CRISPR DNA editing technology, the plan aims to suppress the population similarly to methods used for mosquitoes. The discussion touches on the potential for "garage scientists" to unleash edited organisms into the wild and the broader implications of human DNA editing.

Florida officials consider using genetically modified mosquitoes from the company Oxitec to combat the spread of Zika. The technology, funded in part by the Bill & Melinda Gates Foundation, involves releasing self-limiting insects to reduce the local mosquito population.

Reports from Tehran, Iran, describe an invasion of "super rats" weighing up to 11 pounds that are resistant to poison and require sniper units to eliminate. John C. Dvorak theorizes that these rats are the result of a "genetic cascade" caused by U.S. biological interference. The show concludes with a warning that these mutant rodents could eventually reach New York City.

A news story claiming a derivative of the drug Ecstasy can cure leukemia is deconstructed as a targeted PR campaign against Obamacare. The hosts explain that the research involved only three patients and focused on genetically modifying white blood cells, but the media used the "Ecstasy" hook to gain attention. The segment eventually pivots to claims that government healthcare regulations will stifle such expensive medical breakthroughs.

A discussion of the TV show "Hoarders" leads into a report on a scientific breakthrough in South Korea: a genetically engineered, glow-in-the-dark beagle with an "on and off" switch. Researchers claim the cloning technique used to create the dog will assist in finding treatments for degenerative diseases like Alzheimer's and Parkinson's.

The Institute of Medical Research in Malaysia released 6,000 genetically modified mosquitoes into the wild to test their ability to combat dengue fever. The release was only announced a month after the experiment concluded. Officials stated that public approval was not a requirement for the trial.

The Supreme Court rules in favor of Monsanto, allowing the distribution of genetically modified alfalfa seeds before full environmental testing is completed. The hosts also discuss a project involving genetically engineered mosquitoes with "glowing eyes," expressing concern over the long-term safety of such biological experiments.

New developments in the vaccine industry include a proposed shot to cure phobias like fear of spiders and heights by targeting specific brain receptors. Additionally, Japanese researchers are developing genetically modified mosquitoes designed to deliver vaccines through bites. These advancements are discussed in the context of the new healthcare law, which provides significant funding for the vaccine industry.

A fungal disease threatening global banana supplies leads to a discussion on the potential for Monsanto to introduce genetically modified replacements. Similarly, International Paper and ArborGen are seeking USDA permission to plant genetically engineered forest trees in the United States. The hosts express concern over the "Frankenforest" trend and the industrialization of natural ecosystems.

Monsanto is resuming efforts to produce genetically engineered wheat five years after initial industry resistance. In South America, the company is pushing for legislative changes in Argentina to prevent farmers from saving seeds from previous harvests, effectively mandating annual purchases of transgenic technology.

Monsanto's practice of patenting genetically modified seeds and suing farmers for "seed blowover" or unauthorized reuse is discussed. The hosts mention that even pigs have been patented. The conversation references the 1973 film "Soylent Green" as a seminal cinematic depiction of a corporate-controlled food dystopia.